{"id":"https://genegraph.clinicalgenome.org/r/c9661414-fcea-43de-a313-d18317c527bev1.0","type":"EvidenceStrengthAssertion","dc:description":"There is abundant evidence published associating the EXT2 gene with Hereditary Multiple Exostoses (HME) since the gene-disease relationship was first proposed by Stickens et al. (1996). Multiple case level studies have been performed with HME patients that have variants in the EXT2 gene. EXT1 also cause hereditary multiple exostoses and a working model for the formation of exostoses has been proposed to link the heparan sulfate biosynthesis function of EXT2. Multiple mouse and zebra fish models have been established to show the development of osteochondromas and exostoses with EXT2 deficiency. All of these types of evidence are consistent with a definitive relationship between the EXT2 gene and Hereditary Multiple Exostoses (HME).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/c9661414-fcea-43de-a313-d18317c527be","GCISnapshot":"https://genegraph.clinicalgenome.org/r/9e6829ce-3e0b-44c5-a214-756f33b1e948","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/9e6829ce-3e0b-44c5-a214-756f33b1e948_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-01T00:00:00Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/9e6829ce-3e0b-44c5-a214-756f33b1e948_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2018-12-21T15:31:26.680Z","role":"Approver"}],"curationReasonDescription":"Segregation points should be 1.5, but doesn't change the total points.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e6829ce-3e0b-44c5-a214-756f33b1e948_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e6829ce-3e0b-44c5-a214-756f33b1e948_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c7c956a8-cb68-4faa-aabc-9cf972d1c0d7_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A nonsense mutation.  Maternal and paternal confirmed de novo.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/14241105-adb5-4486-9bdd-d02ce75dc0b2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9326317","rdfs:label":"Family 7 IIP","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Mutation scanning was performed by conformation-sensitive gel electrophoresis (CSGE), a heteroduplex method described by Ganguly et al. (1993).","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":"obo:HP_0002762","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/c7c956a8-cb68-4faa-aabc-9cf972d1c0d7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9326317","allele":{"id":"https://genegraph.clinicalgenome.org/r/76c94118-8a3e-4973-84a5-8e117ca8065b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000011.10:g.44171638C>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA380175187"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/9e6829ce-3e0b-44c5-a214-756f33b1e948_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5f8dc24f-9608-4c2f-9c78-8629ba70f394_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A G-A transition within a 5-prime donor splice site of EXT2, resulting in aberrant splicing, exon skipping, and loss of 94 nucleotides of the transcript (nucleotides 1080-1173) corresponding to amino acid residues alanine-361 through glutamine-391. The deletion also produced a frameshift and generated a stop signal at codon 404.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7c6a0cc3-1b5a-40a3-a50d-9175875f7459","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8894688","rdfs:label":"Family 3","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"SSCP analysis of a genomic PCR fragment of 463 bp amplified with primers A3 and A9 (Table 2) and digested with restriction enzyme SAU3AI, revealed an abnormal pattern which was present in all affected patients, but not in the unaffected family members nor in controls (Fig. 6A).","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":"obo:HP_0002762","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/5f8dc24f-9608-4c2f-9c78-8629ba70f394_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8894688","allele":{"id":"https://genegraph.clinicalgenome.org/r/383faff8-5824-4364-a2e6-bf0632539b54","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000401.3(EXT2):c.1404+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/2473"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a7b954a8-cd9f-4e3d-b7c7-20654fba38f9_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A 514C-T transition in the EXT2 gene, resulting in a stop codon TAA at amino acid position 172 (Q172X), leading to a severely truncated EXT2 protein.\nIncrease points to 2 is because Heinritz et al. (2009) identified the Q172X mutation in a German patient with EXT2.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9651827b-a466-4361-9d4b-33e2b2993b41","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8894688","rdfs:label":"Family 1","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"SSCP analysis of a genomic PCR fragment of 463 bp amplified with primers A3 and A9 (Table 2) and digested with restriction enzyme SAU3AI, revealed an abnormal pattern which was present in all affected patients, but not in the unaffected family members nor in controls (Fig. 6A).","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":"obo:HP_0002762","previousTesting":true,"previousTestingDescription":"PMID: 8162019","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/a7b954a8-cd9f-4e3d-b7c7-20654fba38f9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8894688","allele":{"id":"https://genegraph.clinicalgenome.org/r/15114d82-4ca1-4460-a432-60f820ff41af","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_207122.1(EXT2):c.514C>T (p.Gln172Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/2472"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/22150dc2-c44b-41d2-885e-d3858457e7e3_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A 4-bp deletion (784-787) in the EXT2 gene, resulting in a frameshift and premature termination of translation, generating a truncated EXT2 gene product.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/de14a975-50c6-49ed-a9bc-c3ac70b192c7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8782816","rdfs:label":"Patient H10.1","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Single-strand conformation polymorphism (SSCP)","firstTestingMethod":"PCR","phenotypes":"obo:HP_0002762","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/22150dc2-c44b-41d2-885e-d3858457e7e3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8782816","allele":{"id":"https://genegraph.clinicalgenome.org/r/fbcd3603-88cb-4188-bd50-242c5ed5ce97","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000401.3(EXT2):c.553_556delCTGT (p.Val187Profs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/2471"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/ec89ab28-af75-40fb-8255-17528805d3e6_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A C-G transversion in exon 4 of the EXT2 gene, resulting in a stop codon (Y222X).","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e24cc61f-09a2-48d8-9bfd-eadd2f032441","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9326317","rdfs:label":"Family 2 IVP","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Mutation scanning was performed by conformation-sensitive gel electrophoresis (CSGE), a heteroduplex method described by Ganguly et al. (1993).","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":"obo:HP_0002762","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ec89ab28-af75-40fb-8255-17528805d3e6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9326317","allele":{"id":"https://genegraph.clinicalgenome.org/r/b3d2b1bf-32f9-47b6-8b14-ae53726b39d8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000401.3(EXT2):c.765C>G (p.Tyr255Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/2475"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/4bc5ce2a-69da-4c8c-9f02-1e44bc84511a_proband_score_evidence_line","type":"EvidenceLine","dc:description":"A frameshift mutation (77- or 78insT; family 19); Ser85PhefsTer4","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0501fb6b-7fed-43bb-b4f4-068907249cb3","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9326317","rdfs:label":"Family 19 IIIP","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Mutation scanning was performed by conformation-sensitive gel electrophoresis (CSGE), a heteroduplex method described by Ganguly et al. (1993).","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":"obo:HP_0002762","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4bc5ce2a-69da-4c8c-9f02-1e44bc84511a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9326317","allele":{"id":"https://genegraph.clinicalgenome.org/r/22b32ea4-88e9-4af0-b6dd-45b4afa85a1a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000011.10:g.44107866dup","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658795214"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":8},{"id":"https://genegraph.clinicalgenome.org/r/9e6829ce-3e0b-44c5-a214-756f33b1e948_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f3613e3-cfc9-46e5-b373-6eb222aa88c7_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Heinritz et al. (2009) identified the D227N mutation in 3 unrelated German patients with multiple exostoses.  Although there is no direct functional evidence for this variant, five unrelated families have been reported so far with consistent phenotypes.  Therefore, it was given default points.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/916ed65b-5b66-4443-9545-32ff5da30c21","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9326317","rdfs:label":"Family 6 IIIP","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Mutation scanning was performed by conformation-sensitive gel electrophoresis (CSGE), a heteroduplex method described by Ganguly et al. (1993).","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":"obo:HP_0002762","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/0f3613e3-cfc9-46e5-b373-6eb222aa88c7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9326317","allele":{"id":"https://genegraph.clinicalgenome.org/r/74c679ca-cd60-4265-bdc5-9e6369fbf187","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000401.3(EXT2):c.778G>A (p.Asp260Asn)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/2474"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/3f502a03-39f6-434a-99e5-0f6729e57f9d_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Heinritz et al. (2009) identified the D227N mutation in 3 unrelated German patients with multiple exostoses. Although there is no direct functional evidence for this variant, five unrelated families have been reported so far with consistent phenotypes. Therefore, it was given default points.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/44c5aa6c-86a1-4ec7-af12-ca4c1d453c79","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9326317","rdfs:label":"Family 25 IIP","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Mutation scanning was performed by conformation-sensitive gel electrophoresis (CSGE), a heteroduplex method described by Ganguly et al. (1993).","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypes":"obo:HP_0002762","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/3f502a03-39f6-434a-99e5-0f6729e57f9d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9326317","allele":{"id":"https://genegraph.clinicalgenome.org/r/74c679ca-cd60-4265-bdc5-9e6369fbf187"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/9e6829ce-3e0b-44c5-a214-756f33b1e948_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/974f4817-a54f-44c5-bd66-c0dac2163932_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9326317","rdfs:label":"Family 19","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/974f4817-a54f-44c5-bd66-c0dac2163932","type":"Family","rdfs:label":"Family 19","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/0501fb6b-7fed-43bb-b4f4-068907249cb3"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypePositiveAllelePositive":4,"phenotypes":"obo:HP_0002762","proband":{"id":"https://genegraph.clinicalgenome.org/r/0501fb6b-7fed-43bb-b4f4-068907249cb3"}},{"id":"https://genegraph.clinicalgenome.org/r/2491aaf2-4538-48bc-bc8c-84f9a06bd688_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8894688","rdfs:label":"Family 1","estimatedLodScore":4.52,"family":{"id":"https://genegraph.clinicalgenome.org/r/2491aaf2-4538-48bc-bc8c-84f9a06bd688","type":"Family","rdfs:label":"Family 1","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/9651827b-a466-4361-9d4b-33e2b2993b41"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":16,"phenotypes":"obo:HP_0002762","proband":{"id":"https://genegraph.clinicalgenome.org/r/9651827b-a466-4361-9d4b-33e2b2993b41"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/ed63aba8-c382-4a1e-9730-c728eb9cf852_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9326317","rdfs:label":"Family 7","family":{"id":"https://genegraph.clinicalgenome.org/r/ed63aba8-c382-4a1e-9730-c728eb9cf852","type":"Family","rdfs:label":"Family 7","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/14241105-adb5-4486-9bdd-d02ce75dc0b2"}},"phenotypeFreeText":"","phenotypePositiveAllelePositive":1,"phenotypes":"obo:HP_0002762","proband":{"id":"https://genegraph.clinicalgenome.org/r/14241105-adb5-4486-9bdd-d02ce75dc0b2"}},{"id":"https://genegraph.clinicalgenome.org/r/14785816-7f9f-4d6b-a1e8-1ae4d993c992_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8894688","rdfs:label":"Family 3","family":{"id":"https://genegraph.clinicalgenome.org/r/14785816-7f9f-4d6b-a1e8-1ae4d993c992","type":"Family","rdfs:label":"Family 3","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/7c6a0cc3-1b5a-40a3-a50d-9175875f7459"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":0,"phenotypes":"obo:HP_0002762","proband":{"id":"https://genegraph.clinicalgenome.org/r/7c6a0cc3-1b5a-40a3-a50d-9175875f7459"},"publishedLodScore":2.3,"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/9692e59f-819f-4822-973d-203a4d11c520_proband_segregation","type":"FamilyCosegregation","dc:description":"Only two affected individuals are sequenced.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9326317","rdfs:label":"Family 6","estimatedLodScore":1.51,"family":{"id":"https://genegraph.clinicalgenome.org/r/9692e59f-819f-4822-973d-203a4d11c520","type":"Family","rdfs:label":"Family 6","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/916ed65b-5b66-4443-9545-32ff5da30c21"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypePositiveAllelePositive":6,"phenotypes":"obo:HP_0002762","proband":{"id":"https://genegraph.clinicalgenome.org/r/916ed65b-5b66-4443-9545-32ff5da30c21"}},{"id":"https://genegraph.clinicalgenome.org/r/92a40fbe-1ac2-4af9-b81e-14e563af9a5b_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9326317","rdfs:label":"Family 25","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/92a40fbe-1ac2-4af9-b81e-14e563af9a5b","type":"Family","rdfs:label":"Family 25","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/44c5aa6c-86a1-4ec7-af12-ca4c1d453c79"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0002762","proband":{"id":"https://genegraph.clinicalgenome.org/r/44c5aa6c-86a1-4ec7-af12-ca4c1d453c79"}},{"id":"https://genegraph.clinicalgenome.org/r/d96d5068-31ab-4fe5-a8e1-927384c433e3_proband_segregation","type":"FamilyCosegregation","dc:description":"Only 4 affected individuals be sequenced.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9326317","rdfs:label":"Family 2","estimatedLodScore":3.01,"family":{"id":"https://genegraph.clinicalgenome.org/r/d96d5068-31ab-4fe5-a8e1-927384c433e3","type":"Family","rdfs:label":"Family 2","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/e24cc61f-09a2-48d8-9bfd-eadd2f032441"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypePositiveAllelePositive":11,"phenotypes":"obo:HP_0002762","proband":{"id":"https://genegraph.clinicalgenome.org/r/e24cc61f-09a2-48d8-9bfd-eadd2f032441"}},{"id":"https://genegraph.clinicalgenome.org/r/82956443-2895-4c9a-8d48-d434e670f826_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8782816","rdfs:label":"Family H","estimatedLodScore":2.11,"family":{"id":"https://genegraph.clinicalgenome.org/r/82956443-2895-4c9a-8d48-d434e670f826","type":"Family","rdfs:label":"Family H","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/de14a975-50c6-49ed-a9bc-c3ac70b192c7"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":8,"phenotypes":"obo:HP_0002762","proband":{"id":"https://genegraph.clinicalgenome.org/r/de14a975-50c6-49ed-a9bc-c3ac70b192c7"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/9e6829ce-3e0b-44c5-a214-756f33b1e948_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e6829ce-3e0b-44c5-a214-756f33b1e948_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c4a3e78e-b971-485c-b96a-0b63f23a7e1e","type":"EvidenceLine","dc:description":"Exostoses formed in Ext2 heterozygote mice with all of the features found in human exostoses.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1e50b829-9a85-4e09-aea5-2663bf319b59","type":"Finding","dc:description":"Humans with HME are heterozygous for either EXT1 or EXT2. Close examination of the skeletons of Ext2+/– mice revealed the presence of one or more exostoses on the ribs\nof 7 out of 25 (28%) Ext2 heterozygotes, whereas exostoses were never detected in wild-type animals (Fig.4A,B). In humans, ribs are a common location for exostoses formation, although nearly every bone, with the exception of membranous bones, is involved.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16236767","rdfs:label":"EXT2 deficient mice lack heparan sulfate & develop exostoses","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/57b243c0-76e5-4bd6-b56c-f287fe7dffd0","type":"EvidenceLine","dc:description":"Compound heterozygous mice had nearly twice as many outgrowths and, more importantly, displayed stereotypic growth plate-like exostoses along their long bones. Reduce points to 1 point because this is a Ext1+/− / Ext2+/− compound heterozygous mouse model.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/924cf2eb-a885-4114-9f13-ca70b631b72e","type":"Finding","dc:description":"Compound Ext1/Ext2 heterozygote mice develop exostoses on long bones.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21310272","rdfs:label":"Loss of Ext1 AND Ext2 form ME in mouse long bone","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/1690ced0-2ae6-4af4-a0b0-b3802851a64f","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9790bfc1-40d4-42b4-b6fe-c38a524c4876","type":"Finding","dc:description":"During bone development in the ext2−/− zebrafish, chondrocytes fail to undergo terminal differentiation; and pre-osteoblasts do not differentiate toward osteoblasts. This inadequate osteogenesis coincides with increased deposition of lipids/fats along/in the vessels and premature adipocyte differentiation as shown by biochemical and molecular markers. Also, the ext2-null fish have a muscle phenotype, i.e. muscles are shorter and thicker. These changes coexist with misshapen bones.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24628984","rdfs:label":"Bone development is impaired in the ext2−/− fish.","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/9e6829ce-3e0b-44c5-a214-756f33b1e948_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e53c26b5-9fee-4e7e-bc69-958818a54120","type":"EvidenceLine","dc:description":"Mammalian EXT proteins synthesize HSPGs that are required for the diffusion and/or efficient signaling by Ihh in the growth plate of developing bone (Figure 2).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a69a4fc-5787-4702-9844-79ffd742c14e","type":"Finding","dc:description":"A defect in HS biosynthesis due to a second, somatic mutation in EXT1 or EXT2 would cause a localized disruption in the negative feedback loop that regulates chondrocyte proliferation and maturation, permitting premature differentiation, and thus aberrant bone growth in the immediate region. Furthermore, taking into account the wide range of ligands bound by HS, it has been proposed that HS, and thus the EXT proteins, may also negatively regulate bone growth by mediating the binding of additional factors such as bone morphogenic proteins and FGFs.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11518722","rdfs:label":"A working model for the formation of exostoses","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0bb913bf-2655-4d0e-99df-bc060a72d3d1","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3474d221-fd6a-4ec1-a871-f37eb8ce80e7","type":"Finding","dc:description":"Both EXT (EXT1, EXT2) gene products are involved in the biosynthesis of heparan sulfate. EXT1 and EXT2 encode glycosyltransferases that interact as heterooligomeric complexes [McCormick et al 2000].","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9326317","rdfs:label":"EXT1 also cause hereditary multiple exostoses","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b6745b2a-de11-4523-8678-6ba7d2d309b4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c79ff6c4-679e-4300-bc7c-2f3f814990cb","type":"Finding","dc:description":"Exostosis chondrocytes had greatly diminished levels of EXT1 and EXT2 protein levels. Mutations in exostoses of EXT2 patients 1a, 1b (907insGC, Frame shift) shows reduced EXT2 protein level in Exostosis Chondrocytes.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11169766","rdfs:label":"Diminished EXT2 Proteins Levels in Exostosis Chondrocytes","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5.5}],"evidenceStrength":"Definitive","sequence":578,"specifiedBy":"GeneValidityCriteria6","strengthScore":17.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/sPM08vuQ4ss","type":"GeneValidityProposition","disease":"obo:MONDO_0007586","gene":"hgnc:3513","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_9e6829ce-3e0b-44c5-a214-756f33b1e948-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}